Searching for proteins that interact with and mediate the function of FGFR3∆7–9, we found that that FGFR3∆7–9 can significantly enhance proliferation in HCC cells through the TET2-PTEN-AKT signaling pathway. This evidence concerns the gene AKT1 and hepatocellular carcinoma.